Alps Medical Breakthroughs ETF (SBIO)
$32.84 0.80 (2.38%)
19:59 EDT SBIO Stock Quote Delayed 15 Minutes
Previous Close $32.84
Market Cap 149.42M
PE Ratio -
Volume (Avg. Vol.) 28,000
Day's Range 32.84 - 33.68
52-Week Range 25.49 - 39.61
Dividend & Yield 0.58 (1.76%)
SBIO Stock Predictions, Articles, and Alps Medical Breakthroughs ETF News
- From InvestorPlace
- From the Web
Amid ongoing industry consolidation, attractive valuations and a strong broad market, catalysts are in place for more upside for biotech ETFs.
Biotech ETFs lagged in 2018, but that doesn't mean there aren't healthcare funds to consider for 2019.
As the Best ETFs contest enters its final quarter, there are a few contenders that could reasonably take the trophy for 2018.
On a year-to-date basis, SBIO still looks good, up 14.30%, or 310 basis points better than the Nasdaq Biotechnology Index. Year-to-date, SBIO is also outpacing the equal-weight S&P Biotechnology Select Industry Index.
The third quarter is a notoriously tricky time for stocks, but that doesn't mean you can't continue to profit. Here are some ETFs to buy to beat the market in Q3.
As our Best ETFs for 2018 contest crosses into the second half of the year, a few contestants are really making standout gains, but others are making strong moves.
We have presented five ETFs & stocks that have easily crushed the Russell 2000 index this year and are likely to continue their strong performance. Compare....
While some of the contenders have been gravitating toward the top or bottom, it's still very much anyone's game in the Best ETFs for 2018 contest.
My pick for the Best ETFs contest, SBIO, is outpacing the Nasdaq Biotechnology Index by 600 basis points with the first quarter drawing to a close.
Some of the best healthcare ETFs to buy are more "traditional", while others focus on very specific areas of the industry. These seven healthcare ETFs should deliver for investors over the remainder of 2018.
Trying to pick just the right biotech stock to invest in? The ALPS Medical Breakthroughs ETF (SBIO) eases that burden.
Let's take a look Inside four heavily losing ETFs in the year-to-date frame.
By Jeff Reeves
The best ETFs so far in 2015 include some lesser-known funds dealing in niches like small-cap health care and Japanese financials.
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!